Optimising percutaneous valve-in-valve TAVI with bioprosthetic valve fracture
Percutaneous transcatheter aortic valve implantation (TAVI) has become an established therapy for inoperable patients, for high, intermediate and low surgical-risk patients over 65 years old with severe aortic valve stenosis (AS).1,2 Valve-in-valve (ViV) TAVI is an approved indication for patients...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Academy of Medicine Singapore
2024-05-01
|
| Rangatū: | Annals, Academy of Medicine, Singapore |
| Urunga tuihono: | https://annals.edu.sg/optimising-percutaneous-valve-in-valve-tavi-with-bioprosthetic-valve-fracture/ |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|